Bio-Rad's Amplichek II Quality Control
May 25, 2016
Bio-Rad Laboratories has launched the Amplichek II, an independent, multi-analyte quality control test that monitors the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of healthcare-associated infections. It was recently issued a de novo clearance from the US Food and Drug Administration, and it is the first in a series of infectious disease controls that Bio-Rad plans to introduce to the molecular diagnostic testing market, the company said.